What Are GLP-1 Medications, and Why Are They So Expensive
The problem is not a lack of science
Pipeline timelines are indicative estimates
Here's how BPC-157 differs: Unlike NSAIDs, BPC-157 does not carry the risk of stomach irritation or long-term organ damage Unlike steroids, it does not suppress your body's healing process or cause dependency It can complement, rather than replace, physical therapy or rehab It supports healing at the source instead of just managing symptoms For individuals seeking natural alternatives that are safe, effective, and science-backed, peptide therapy stands out
The role of oxidative stress in the pathogenesis of IBD is well-documented, with high levels of reactive ROS and RNS contributing to gut mucosal damage and the activation of inflammatory pathways
Racial Disparities in Access One of the most concerning aspects of the GLP-1 market is the racial disparities in access